{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:15Z","timestamp":1790673195026,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.09.032","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T11:01:00Z","timestamp":1505386860000},"page":"1082-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice"],"prefix":"10.1016","volume":"95","author":[{"given":"Muhammad","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaragurubaran","family":"Karthik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Dingding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.21038","article-title":"Global levels of histone modifications predict prostate cancer recurrence","volume":"70","author":"Ellinger","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2017.09.032_bib0010","first-page":"51","article-title":"Gastric cancer and Helicobacter pylori infection","volume":"57","author":"Konturek","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/apt.12814","article-title":"The epidemiology and prevention of gastric cancer","volume":"40","author":"Fock","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2017.09.032_bib0020","first-page":"333","article-title":"Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125","volume":"7","author":"Szymendera","year":"1986","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jso.23262","article-title":"Gastric cancer epidemiology and risk factors","volume":"107","author":"Guggenheim","year":"2013","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2017.09.032_bib0040","series-title":"Cancer Biomarkers-Current Perspectives","author":"Bhatt","year":"2010"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1073\/pnas.0506655103","article-title":"Molecular analysis of the bacterial microbiota in the human stomach","volume":"103","author":"Bik","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10120-014-0355-1","article-title":"Clinical significance of RacGAP1 expression at the invasive front of gastric cancer","volume":"18","author":"Saigusa","year":"2015","journal-title":"Gastric Cancer"},{"issue":"156","key":"10.1016\/j.biopha.2017.09.032_bib0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004504","article-title":"Methylation subtypes and large-scale epigenetic alterations in gastric cancer","volume":"4","author":"Zouridis","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0060","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.7314\/APJCP.2013.14.6.3437","article-title":"Serum protein and genetic tumor markers of gastric carcinoma","volume":"14","author":"He","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0065","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","article-title":"Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer\u2014pooled analysis from three multicenter, randomized, controlled trials using individual patient data","volume":"22","author":"Chau","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"18","key":"10.1016\/j.biopha.2017.09.032_bib0075","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10120-011-0042-4","article-title":"Japanese gastric cancer treatment guidelines 2010 (ver. 3)","volume":"14","author":"Association","year":"2011","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2017.09.032_bib0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1756283X12450246","article-title":"Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer","volume":"5","author":"Okines","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"17","key":"10.1016\/j.biopha.2017.09.032_bib0095","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.2010.553","article-title":"Gastric cancer\u2014an enigmatic and heterogeneous disease","volume":"303","author":"Shah","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0300-1652.108884","article-title":"Helicobacter pylori eradication therapy: a review of current trends","volume":"54","author":"Olokoba","year":"2013","journal-title":"Nig. Med. J."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1084\/jem.122.3.467","article-title":"Specific carcinoembryonic antigens of the human digestive system","volume":"122","author":"Gold","year":"1965","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2013.06.005","article-title":"Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma","volume":"140","author":"T\u00e4nzer","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0115","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1097-0142(19801215)46:12<2686::AID-CNCR2820461225>3.0.CO;2-E","article-title":"Carcinoembryonic antigen in gastric juice as an aid in diagnosis of early gastric cancer","volume":"46","author":"Tatsuta","year":"1980","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1096-9098(200007)74:3<185::AID-JSO4>3.0.CO;2-0","article-title":"Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients","volume":"74","author":"Kim","year":"2000","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.1044","article-title":"The prognostic significance of preoperative serum CA 19\u00c79 in patients with resectable gastric carcinoma: comparison with CEA","volume":"76","author":"Duraker","year":"2001","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004836-200101000-00010","article-title":"Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer","volume":"32","author":"Ishigami","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/172460080301800104","article-title":"Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer","volume":"18","author":"Aloe","year":"2002","journal-title":"Int. J. Biol. Mark."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0140","first-page":"A19","article-title":"The prognostic value of preoperative serum levels of CEA and C-9 in patients with gastric cancer","volume":"91","author":"Kodera","year":"1996","journal-title":"Am. J. Gastroenterol."},{"issue":"15","key":"10.1016\/j.biopha.2017.09.032_bib0145","first-page":"866","article-title":"Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma","volume":"44","author":"Ikeguchi","year":"1997","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000030038","article-title":"Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients","volume":"19","author":"Nakajima","year":"1998","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02469853","article-title":"Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy","volume":"15","author":"Tamada","year":"1985","journal-title":"Jpn. J. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0160","first-page":"342","article-title":"The clinical usefulness of preoperative CEA determination in gastric cancer","volume":"17","author":"Koga","year":"1987","journal-title":"Surg. Today"},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jso.2930530409","article-title":"Carcinoembryonic antigen (CEA) in stage IV gastric cancer as a risk factor for liver metastasis: a univariate and multivariate analysis","volume":"53","author":"Ikeda","year":"1993","journal-title":"J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2017.09.032_bib0170","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12325-008-0100-4","article-title":"Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer","volume":"25","author":"Ucar","year":"2008","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0175","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ijc.20321","article-title":"Preoperative hCG\u03b2 and CA 72-4 are prognostic factors in gastric cancer","volume":"111","author":"Louhimo","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"59","key":"10.1016\/j.biopha.2017.09.032_bib0180","first-page":"1544","article-title":"The use of tumor markers as predictors of prognosis in gastric cancer","volume":"51","author":"Mihmanli","year":"2004","journal-title":"Hepato-Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10120-009-0509-8","article-title":"Serum interleukin-6 and-10 levels in patients with gastric cancer","volume":"12","author":"Ikeguchi","year":"2009","journal-title":"Gastric Cancer"},{"issue":"105","key":"10.1016\/j.biopha.2017.09.032_bib0190","first-page":"239","article-title":"Investigation of serum tumor markers in the diagnosis of gastric cancer","volume":"58","author":"Fan","year":"2010","journal-title":"Hepato-Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000050633","article-title":"Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma","volume":"22","author":"Gaspar","year":"2001","journal-title":"Tumor Biol."},{"issue":"13","key":"10.1016\/j.biopha.2017.09.032_bib0200","first-page":"3952","article-title":"Serum carcinoembryonic antigen level increases correlate with tumor progression in patients with differentiated gastric carcinoma following noncurative resection","volume":"50","author":"Maehara","year":"1990","journal-title":"Cancer Res."},{"issue":"8\u20139","key":"10.1016\/j.biopha.2017.09.032_bib0205","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0959-8049(92)90517-6","article-title":"CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer","volume":"28","author":"Hamazoe","year":"1992","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jso.2930370105","article-title":"Immunohistochemical study of carcinoembryonic antigen (CEA) in gastric tumors: correlation with preoperative serum levels, histologic type, and grade of anaplasia of the tumor","volume":"37","author":"Santeusanio","year":"1988","journal-title":"J. Surg. Oncol."},{"issue":"99","key":"10.1016\/j.biopha.2017.09.032_bib0215","first-page":"674","volume":"57","author":"Dilege","year":"2010","journal-title":"Hepato-Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000227515","article-title":"Prognostic value of combination assays for CEA and CA 19-9 in gastric cancer","volume":"52","author":"Ikeda","year":"1995","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000012001","article-title":"Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma","volume":"57","author":"Marrelli","year":"1999","journal-title":"Oncology"},{"issue":"6B","key":"10.1016\/j.biopha.2017.09.032_bib0230","first-page":"2409","article-title":"Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma","volume":"13","author":"Guadagni","year":"1993","journal-title":"Anticancer Res."},{"issue":"4B","key":"10.1016\/j.biopha.2017.09.032_bib0235","first-page":"2241","article-title":"Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients","volume":"16","author":"Spila","year":"1996","journal-title":"Anticancer Res."},{"issue":"76","key":"10.1016\/j.biopha.2017.09.032_bib0240","first-page":"1272","article-title":"Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer","volume":"54","author":"Goral","year":"2007","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.biopha.2017.09.032_bib0245","article-title":"Tumor markers in monitoring response to chemotherapy for patients with gastric cancer","author":"Ohkura","year":"1999","journal-title":"Found. Promot. Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0250","first-page":"255","article-title":"CA 50: a tumor marker for gastrointestinal malignancies","volume":"78","author":"Bunworasate","year":"1995","journal-title":"J. Med. Assoc. Thail. = Chotmaihet thangphaet"},{"key":"10.1016\/j.biopha.2017.09.032_bib0255","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<795::AID-IJC4>3.0.CO;2-Y","article-title":"A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4","volume":"73","author":"Akashi","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<280::AID-CNCR6>3.0.CO;2-7","article-title":"Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique","volume":"88","author":"Ren","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1440-1746.2005.03797.x","article-title":"Bird\u2019s-eye view on gastric cancer research of the past 25 years","volume":"20","author":"Fan","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0888-7543(89)90292-9","article-title":"Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21. 1-pter","volume":"4","author":"Pals","year":"1989","journal-title":"Genomics"},{"issue":"96","key":"10.1016\/j.biopha.2017.09.032_bib0275","first-page":"1750","article-title":"Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy","volume":"56","author":"Zhang","year":"2008","journal-title":"Hepato-Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0280","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4161\/15384047.2014.972264","article-title":"Calcium calmodulin dependent kinase kinase 2-a novel therapeutic target for gastric adenocarcinoma","volume":"16","author":"Subbannayya","year":"2015","journal-title":"Cancer. Biol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2017.09.032_bib0285","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target","volume":"19","author":"Gravalos","year":"2008","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0295","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-10-3220","article-title":"Cancer stem cell niche: the place to be","volume":"71","author":"Borovski","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(00)00677-7","article-title":"Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients","volume":"163","author":"Okada","year":"2001","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2013.03.035","article-title":"Gastric cancer stem cells: a novel therapeutic target","volume":"338","author":"Singh","year":"2013","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jjco\/hyp020","article-title":"Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma","volume":"39","author":"Song","year":"2009","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0320","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(12)70102-X","article-title":"Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis","volume":"13","author":"Liu","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1470-2045(09)70343-2","article-title":"Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis","volume":"11","author":"Ueda","year":"2010","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0330","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-09-2777","article-title":"MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3\u03b6","volume":"70","author":"Tsukamoto","year":"2010","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2017.09.032_bib0335","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-10-3152","article-title":"Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer","volume":"17","author":"Oh","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.biopha.2017.09.032_bib0340","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1111\/febs.12013","article-title":"Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth","volume":"279","author":"He","year":"2012","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.biopha.2017.09.032_bib0345","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.febslet.2012.05.050","article-title":"Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK","volume":"586","author":"Wang","year":"2012","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.biopha.2017.09.032_bib0350","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2012.02.016","article-title":"MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer","volume":"44","author":"Yamanaka","year":"2012","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0355","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s13277-012-0632-8","article-title":"Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells","volume":"34","author":"Cao","year":"2013","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-11-71","article-title":"microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-\u03baB by targeting CARD10 and COPS8 in gastric cancer","volume":"11","author":"Crone","year":"2012","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0365","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1038\/cddis.2012.160","article-title":"miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer","volume":"3","author":"Sacconi","year":"2012","journal-title":"Cell. Death. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0370","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/onc.2011.340","article-title":"MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1","volume":"31","author":"Xu","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0375","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s13277-012-0497-x","article-title":"Gastric juice microRNA-421 is a new biomarker for screening gastric cancer","volume":"33","author":"Zhang","year":"2012","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12032-012-0365-y","article-title":"Gastric juice miR-129 as a potential biomarker for screening gastric cancer","volume":"30","author":"Yu","year":"2013","journal-title":"Med. Oncol."},{"issue":"2A","key":"10.1016\/j.biopha.2017.09.032_bib0385","first-page":"907","article-title":"miR-21 microRNA expression in human gastric carcinomas and its clinical association","volume":"28","author":"Chan","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2017.09.032_bib0390","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435656","article-title":"Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancer","author":"Wu","year":"2015","journal-title":"Dis. Mark."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0395","first-page":"537","article-title":"microRNA expression profile in undifferentiated gastric cancer","volume":"34","author":"Katada","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2012.05.003","article-title":"MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers","volume":"143","author":"Song","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.09.032_bib0405","doi-asserted-by":"crossref","DOI":"10.1136\/jcp.2010.087858","article-title":"Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis","author":"Compare","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2017.09.032_bib0410","first-page":"2012","article-title":"Genetic aspects of gastric cancer instability","author":"Hudler","year":"2012","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0415","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2010.05.017","article-title":"Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma","volume":"297","author":"Ling","year":"2010","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B","article-title":"Mutations of the transforming growth factor \u03b2 type II receptor gene and microsatellite instability in gastric cancer","volume":"68","author":"Ohue","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0425","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<428::AID-PATH264>3.0.CO;2-A","article-title":"Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-\u03b2 type II receptor, IGFII receptor, and BAX genes","volume":"187","author":"Iacopetta","year":"1999","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0430","first-page":"1090","article-title":"Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability","volume":"59","author":"Fleisher","year":"1999","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0435","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/1097-0215(20000720)89:4<378::AID-IJC10>3.0.CO;2-T","article-title":"Prognostic implications of microsatellite genotypes in gastric carcinoma","volume":"89","author":"Choi","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2017.09.032_bib0440","first-page":"1749","article-title":"Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer","volume":"4","author":"Wirtz","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.09.032_bib0445","doi-asserted-by":"crossref","unstructured":"N. dos Santos, R. Seruca, M. Constancia, M. Seixas, M. Sobrinho-Simoes, Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis, (1996).","DOI":"10.1053\/gast.1996.v110.pm8536886"},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0450","first-page":"137","article-title":"Expression of epidermal growth factor receptor in human gastric and colonic carcinomas","volume":"48","author":"Yasui","year":"1988","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0455","first-page":"1047","article-title":"Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas","volume":"77","author":"Sakai","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0460","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1245\/ASO.2003.05.010","article-title":"Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer","volume":"10","author":"Garcia","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2017.09.032_bib0465","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-12-1318","article-title":"Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II\/III gastric cancer","author":"Terashima","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0470","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1477-7819-10-274","article-title":"Prognosis significance of HER-2\/neu overexpression\/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial","volume":"10","author":"Zhou","year":"2012","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0475","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0463.2012.02942.x","article-title":"The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma","volume":"121","author":"Kim","year":"2013","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.biopha.2017.09.032_bib0480","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jso.23153","article-title":"The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients","volume":"106","author":"Ye","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2017.09.032_bib0485","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-10-1080","article-title":"MET expression and amplification in patients with localized gastric cancer","author":"Janjigian","year":"2011","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"issue":"36","key":"10.1016\/j.biopha.2017.09.032_bib0490","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1200\/JCO.2011.36.7706","article-title":"Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer","volume":"29","author":"Graziano","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0495","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000065477","article-title":"c-Met expression in gastric cancer with liver metastasis","volume":"63","author":"Amemiya","year":"2002","journal-title":"Oncology"},{"issue":"36","key":"10.1016\/j.biopha.2017.09.032_bib0500","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1200\/JCO.2011.35.4928","article-title":"MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib","volume":"29","author":"Lennerz","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2017.09.032_bib0505","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(14)70023-3","article-title":"Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study","volume":"15","author":"Iveson","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0510","article-title":"IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits","volume":"21","author":"Necula","year":"2012","journal-title":"J. Gastrointest. Liver Dis."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0515","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1097-0142(19940601)73:11<2703::AID-CNCR2820731109>3.0.CO;2-X","article-title":"Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients","volume":"73","author":"Nakane","year":"1994","journal-title":"Cancer"},{"issue":"4B","key":"10.1016\/j.biopha.2017.09.032_bib0520","first-page":"2903","article-title":"Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma","volume":"17","author":"Reiter","year":"1997","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0525","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1072-7515(98)00133-1","article-title":"Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer","volume":"187","author":"Tachibana","year":"1998","journal-title":"J. Am. Coll. Surg."},{"issue":"8","key":"10.1016\/j.biopha.2017.09.032_bib0530","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004320050198","article-title":"The role of serum and gastric juice levels of carcinoembryonic antigen, CA19. 9 and CA72. 4 in patients with gastric cancer","volume":"124","author":"Tocchi","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0535","first-page":"4451","article-title":"Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer","volume":"29","author":"Warnecke-Eberz","year":"2009","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0540","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/1078-0432.CCR-07-1032","article-title":"Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma","volume":"14","author":"Liao","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2B","key":"10.1016\/j.biopha.2017.09.032_bib0545","first-page":"1277","article-title":"Prognostic significance of the local expression of interleukin-12 in patients with advanced gastric cancer","volume":"28","author":"Nagashima","year":"2008","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0550","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10120-005-0315-x","article-title":"Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor","volume":"8","author":"Ashizawa","year":"2005","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2017.09.032_bib0555","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2005.02.345","article-title":"Prognostic role of interleukin-1\u03b2 gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer","volume":"23","author":"Graziano","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0560","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13547500600565677","article-title":"Serum levels of interleukin 1\u03b2, interleukin 8 and tumour necrosis factor \u03b1 as markers of gastric cancer","volume":"11","author":"Macri","year":"2006","journal-title":"Biomarkers"},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0565","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/ijc.22599","article-title":"IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src\/RhoA\/ROCK signaling pathway","volume":"120","author":"Lin","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0570","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/SLA.0b013e3181a77ccc","article-title":"The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer","volume":"249","author":"Lee","year":"2009","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0575","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.20324","article-title":"The prognostic significance of p53, p27kip1, p21waf1, HER-2\/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients","volume":"91","author":"Al-Moundhri","year":"2005","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0580","first-page":"405","article-title":"A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes","volume":"24","author":"Tenderenda","year":"2005","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0585","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jso.10172","article-title":"Low level of p27 (Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome","volume":"81","author":"Nitti","year":"2002","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0590","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/1097-0142(20000915)89:6<1214::AID-CNCR4>3.0.CO;2-0","article-title":"The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma","volume":"89","author":"Xiangming","year":"2000","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0595","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/1097-0142(20001201)89:11<2247::AID-CNCR13>3.0.CO;2-5","article-title":"Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas","volume":"89","author":"Sgambato","year":"2000","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.biopha.2017.09.032_bib0600","first-page":"546","article-title":"Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer","volume":"44","author":"Ichiyoshi","year":"1997","journal-title":"Hepato-Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2017.09.032_bib0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12253-010-9333-z","article-title":"Prognostic significance of p53 protein expression in early gastric cancer","volume":"17","author":"Gon\u00e7alves","year":"2011","journal-title":"Pathol. Oncol. Res."},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0610","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2003.07.005","article-title":"Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival","volume":"34","author":"Feakins","year":"2003","journal-title":"Hum. Pathol."},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0615","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/000313480907501207","article-title":"Apoptosis and microvessel density in gastric cancer: correlation with tumor stage and prognosis","volume":"75","author":"Aurello","year":"2009","journal-title":"Am. Surg."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0620","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/bjc.1997.60","article-title":"Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study","volume":"75","author":"Koshida","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"3B","key":"10.1016\/j.biopha.2017.09.032_bib0625","first-page":"2003","article-title":"Bcl-2 expression as a prognostic factor of survival of gastric carcinoma","volume":"18","author":"Inada","year":"1997","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0630","first-page":"85","article-title":"Apoptosis and Bbcl-2 expression in gastric carcinomas: correlation withclinicopathological variables, p53 expression, cell proliferation and prognosis","volume":"14","author":"Aizawa","year":"1999","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0635","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10120-001-8010-z","article-title":"Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis","volume":"4","author":"Osaki","year":"2001","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0640","first-page":"1157","article-title":"Expression of Fas ligand in gastric carcinoma relates to lymph node metastasis","volume":"18","author":"Nagashima","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2017.09.032_bib0645","doi-asserted-by":"crossref","first-page":"e29670","DOI":"10.1371\/journal.pone.0029670","article-title":"The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2017.09.032_bib0650","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00384-003-0491-2","article-title":"Prognostic significance of Bcl-2 and p53 expression in gastric cancer","volume":"18","author":"Lee","year":"2003","journal-title":"Int. J. Colorectal Dis."},{"issue":"5","key":"10.1016\/j.biopha.2017.09.032_bib0655","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00428-011-1150-6","article-title":"Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma","volume":"459","author":"Kim","year":"2011","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0660","first-page":"271","article-title":"Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma","volume":"33","author":"Komatsu","year":"2013","journal-title":"Anticancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0665","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s10620-006-9166-5","article-title":"Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy","volume":"51","author":"Choi","year":"2006","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2017.09.032_bib0670","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jjco\/29.11.550","article-title":"Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer","volume":"29","author":"Yamao","year":"1999","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2017.09.032_bib0675","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","article-title":"Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association","volume":"17","author":"Shimada","year":"2014","journal-title":"Gastric Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2017.09.032_bib0680","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201100153","article-title":"Genomic biomarkers in predictive medicine. An interim analysis","volume":"3","author":"Simon","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2017.09.032_bib0685","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/OTT.S101687","article-title":"Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis","volume":"9","author":"Zhao","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0690","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0929-6646(11)60038-7","article-title":"Prognostic predictors of outcome in an operative series in traumatic brain injury patients","volume":"110","author":"Kuo","year":"2011","journal-title":"J. Formos. Med. Assoc."},{"issue":"3","key":"10.1016\/j.biopha.2017.09.032_bib0695","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2008.10.004","article-title":"The footprints of cancer development: cancer biomarkers","volume":"35","author":"Ullah","year":"2009","journal-title":"Cancer Treat. Rev."},{"issue":"3A","key":"10.1016\/j.biopha.2017.09.032_bib0700","first-page":"1247","article-title":"Proteomic approaches for serum biomarker discovery in cancer","volume":"27","author":"Maurya","year":"2007","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.09.032_bib0705","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3892\/ol.2015.2959","article-title":"Biomarkers for gastric cancer: progression in early diagnosis and prognosis","volume":"9","author":"Jin","year":"2015","journal-title":"Oncol. Lett."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217324812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217324812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:50:11Z","timestamp":1771401011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217324812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":141,"alternative-id":["S0753332217324812"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.032","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}